Monville Christelle, Morizur Lise, Karim Ben M'Barek
{"title":"视网膜疾病细胞疗法的挑战。","authors":"Monville Christelle, Morizur Lise, Karim Ben M'Barek","doi":"10.1016/bs.irn.2022.09.004","DOIUrl":null,"url":null,"abstract":"<p><p>Because retinal cells could not regenerate in mammals, retinal degeneration is an irreversible phenomenon caused by various disease conditions including age-related macular degeneration (AMD) and retinitis pigmentosa (RP). During the course of these diseases, photoreceptors (PRs) are susceptible to degenerate due to their malfunctions or to a primary dysfunction of the retinal pigment epithelium (RPE). These diseases affect millions of individuals worldwide. Many therapies currently under development are designed to treat retinal pathologies and among those, cell-based replacement strategies hold significant promise for treatment of retinal degenerative diseases, especially when atrophy of retinal tissue occurs. This review will focus on the use of hPSCs to slow-down or treat retinal disorders and discuss current challenges to achieve successful engraftment of cell products.</p>","PeriodicalId":14468,"journal":{"name":"International review of neurobiology","volume":" ","pages":"49-77"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Challenges of cell therapies for retinal diseases.\",\"authors\":\"Monville Christelle, Morizur Lise, Karim Ben M'Barek\",\"doi\":\"10.1016/bs.irn.2022.09.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Because retinal cells could not regenerate in mammals, retinal degeneration is an irreversible phenomenon caused by various disease conditions including age-related macular degeneration (AMD) and retinitis pigmentosa (RP). During the course of these diseases, photoreceptors (PRs) are susceptible to degenerate due to their malfunctions or to a primary dysfunction of the retinal pigment epithelium (RPE). These diseases affect millions of individuals worldwide. Many therapies currently under development are designed to treat retinal pathologies and among those, cell-based replacement strategies hold significant promise for treatment of retinal degenerative diseases, especially when atrophy of retinal tissue occurs. This review will focus on the use of hPSCs to slow-down or treat retinal disorders and discuss current challenges to achieve successful engraftment of cell products.</p>\",\"PeriodicalId\":14468,\"journal\":{\"name\":\"International review of neurobiology\",\"volume\":\" \",\"pages\":\"49-77\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International review of neurobiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/bs.irn.2022.09.004\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/10/21 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International review of neurobiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/bs.irn.2022.09.004","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/10/21 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
Challenges of cell therapies for retinal diseases.
Because retinal cells could not regenerate in mammals, retinal degeneration is an irreversible phenomenon caused by various disease conditions including age-related macular degeneration (AMD) and retinitis pigmentosa (RP). During the course of these diseases, photoreceptors (PRs) are susceptible to degenerate due to their malfunctions or to a primary dysfunction of the retinal pigment epithelium (RPE). These diseases affect millions of individuals worldwide. Many therapies currently under development are designed to treat retinal pathologies and among those, cell-based replacement strategies hold significant promise for treatment of retinal degenerative diseases, especially when atrophy of retinal tissue occurs. This review will focus on the use of hPSCs to slow-down or treat retinal disorders and discuss current challenges to achieve successful engraftment of cell products.
期刊介绍：
Published since 1959, International Review of Neurobiology is a well-established series appealing to neuroscientists, clinicians, psychologists, physiologists and pharmacologists. Led by an internationally renowned editorial board, this important serial publishes both eclectic volumes made up of timely reviews and thematic volumes that focus on recent progress in a specific area of neurobiology research.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
